JPT(òÆ¡Ã)
JPT Online
RCTEßÌÕ°±_¶æè
Placebo-controlled double-blind study of recombinant growth hormone for adult patients with growth hormone deficiency
Late phase II study of sepimostat mesilate(FUT-187)in postgastrectomy reflux esophagitis
|Clinical optimum dose in a double blind study|
Pharmacokinetic interaction between ampiroxicam and antiacid
Phase I study of a new antianxiety drug,SC-48274
The phase I study of high moleculer weight sodium hyaluronate(NRD101), a new anti-arthritis agent
A phase I study of calcium mupirocin 2% nasal ointment
|Safety and pharmacokinetic profile of mupirocin following nasal application in healthy male Japanese subjects|
A phase I study of granisetron hydrochloride(1)
|The safety of single oral administration in healthy Japanese subjects|
Clinical Evaluation of RPY-005, a low molecular weight heparin, for extracorporeal circulation during hemodialysis in patients with chronic renal insufficiency
|A double-blind cross-over comparative study with heparin|
Phase I study of vamicamide(1)
|Single-and multiple dose studies|
Phase I study of vamicamide(2)
|Single-and multiple dose studies|
Safety tolerance and pharmacokinetics of milrinone in phase I study in healthy male apanese subjects(2)
|After intravenous infusion|
The effect of nizatidine on gastric emptying and plasma gastrin concentration in patients with peptic ulcer
A phase 1 clinical study of EPOCHiepoetin betaj
|A multiple subcutaneous does study|
Clinical study of triazolam on sleep disorders in psychiatric aspect
|Comparative cross-over study with zopiclone|
Evaluation of pharmacokinetics of sustained release formulation of bunazosin(E1015) compared to sugar-coated plain tavlets(Detantol )and effect of food on pharmacokinetics of E1015
Results of phase I multiple dose study with NB-818,a new calcium channel blocker
Skin reactions to nitrate tapes at the early stage of application
Ursodeoxycholic acid for chronic non-A,non-B hepatitis
|A dose-response study|
Phase I Studyisingle administrationjof CBM 36-733